Saudi Arabia's Ministry of Health (MOH) reported another MERS-CoV case, which involves a 70-year-old woman from Riyadh, the country's capital. In a related development, the World Health Organization Eastern Mediterranean regional office (WHO EMRO) shared new details about a string of recent cases in the Saudi city of Khafji in April, which it said included two clusters.
Forty-two percent of the nursing homes enrolled in the National Healthcare Safety Network (NHSN) met all seven of the Centers for Disease Control and Prevention's (CDC's) Core Elements of Antibiotic Stewardship in 2016, CDC researchers reported today in Clinical Infectious Diseases.
A surveillance study by Chinese scientists has found multidrug-resistant Escherichia coli strains in food products carrying the MCR-1 and blaNDM-1 resistance genes, and mobile genetic elements similar to those found in human strains, according to a paper yesterday in Eurosurveillance.
As has been the case, California, Florida, New York, and Texas reported half of all TB cases.
The US Centers for Disease Control and Prevention (CDC) last month quietly downgraded its travel restriction guidelines for pregnant women, the Washington Post reported yesterday.
Researchers at a large tertiary-care teaching hospital in Chicago reported today in Infection Control and Epidemiology that more than a third of healthcare workers were contaminated with a multidrug-resistant organism (MDRO) after caring for patients infected or colonized with the bacteria, and that errors in doffing personal protective equipment increased the risk of contamination.
Though incidence is down, treatment success for resistant strains is low.
Short-course therapy led to a favorable outcome in 79% of patients, compared with 80% in long-course patients.
A new study by pharmacists with a Veterans Affairs (VA) hospital in upstate New York has found that 40% of the antibiotics prescribed for outpatients were inappropriate. The findings appeared in the American Journal of Infection Control.
The accuracy of tuberculosis (TB) drug-susceptibility testing in high-burden countries was inadequate, and inaccurate test results led to inadequate treatment that contributed to higher mortality in patients with drug-resistant forms of the disease, an international team of researchers reported yesterday in The Lancet Infectious Diseases.
